HPV vaccine (Gardasil 9) cost in Ann Arbor, MI — inpatient
In Ann Arbor, MI, 1 hospital lists a cash price for HPV vaccine, 9-valent (Gardasil 9) as an inpatient: from $180.76 to $180.76, with a median of $180.76. Across Michigan, the median is $394.07 at 33 hospitals.
Cash prices at 1 facility for code 90651, as an inpatient (admitted to hospital) . Collected Sep 23, 2026; the hospital files themselves were last updated between — and —.
Where each hospital's price falls
Each dot is one hospital's cash price on a scale from the lowest to the highest in Ann Arbor, MI.
Hospitals, cheapest first
| Hospital | Cash price | List price | Insurers pay | Off list | File date |
|---|---|---|---|---|---|
| University of Michigan Health lowest Ann Arbor, MI · (734) 764-1505 HUMAN PAPILLOMAVIRUS VACCINE,9-VALENT (PF) 0.5 ML IM SUSPENSION | $180.76 | $451.91 | $194.32–$480.33 | 60% | — source file |
| University of Michigan Health Ann Arbor, MI · (734) 764-1505 HC-Hpv Virus Vaccine 9 Val Im | $193.20 | $483.00 | $207.69–$513.37 | 60% | — source file |
| University of Michigan Health Ann Arbor, MI · (734) 764-1505 HUMAN PAPILLOMAVIRUS VACCINE,9-VALENT(PF) 0.5 ML INTRAMUSCULAR SYRINGE | $238.62 | $596.55 | $256.52–$634.06 | 60% | — source file |
Inpatient: lowest $180.76, median $180.76, highest $180.76.
As an outpatient, the same code is billed by 1 facility here, median $180.76 — that is the price to compare if you are not being admitted.
Cash or insurance?
At the one hospital here that publishes insurer rates for this code, the cash price is below the highest rate a health plan has negotiated and below every plan's rate. If you have insurance but have not met your deductible, you usually pay your plan's negotiated rate, which falls somewhere in the "Insurers pay" column. Paying cash can cost less, but a cash payment usually does not count toward your deductible. Ask the hospital for both numbers before you book.
What it is
Gardasil 9 protects against nine types of HPV, the virus behind most cervical cancers and several other cancers. It is routine at ages 11 to 12 and recommended through age 26; adults 27 to 45 may get it after talking with a doctor.
What the price covers
The price is for one dose. , and the series takes two or three doses.